- Home
- BOLT vs ADGM Comparison
BOLT vs ADGM Comparison
Compare BOLT & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- ADGM
- Stock Information
- Founded
- BOLT 2015
- ADGM 2011
- Country
- BOLT United States
- ADGM United States
- Employees
- BOLT N/A
- ADGM N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- ADGM
- Sector
- BOLT Health Care
- ADGM
- Exchange
- BOLT Nasdaq
- ADGM NYSE
- Market Cap
- BOLT 16.8M
- ADGM 19.7M
- IPO Year
- BOLT 2021
- ADGM N/A
- Fundamental
- Price
- BOLT $0.35
- ADGM $1.22
- Analyst Decision
- BOLT Hold
- ADGM
- Analyst Count
- BOLT 5
- ADGM 0
- Target Price
- BOLT $1.00
- ADGM N/A
- AVG Volume (30 Days)
- BOLT 103.8K
- ADGM 6.1M
- Earning Date
- BOLT 05-12-2025
- ADGM 05-23-2025
- Dividend Yield
- BOLT N/A
- ADGM N/A
- EPS Growth
- BOLT N/A
- ADGM N/A
- EPS
- BOLT N/A
- ADGM N/A
- Revenue
- BOLT $3,638,000.00
- ADGM $602,000.00
- Revenue This Year
- BOLT N/A
- ADGM N/A
- Revenue Next Year
- BOLT $77.48
- ADGM N/A
- P/E Ratio
- BOLT N/A
- ADGM N/A
- Revenue Growth
- BOLT N/A
- ADGM 100.67
- 52 Week Low
- BOLT $0.30
- ADGM $0.63
- 52 Week High
- BOLT $1.34
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- BOLT 45.53
- ADGM N/A
- Support Level
- BOLT $0.35
- ADGM N/A
- Resistance Level
- BOLT $0.38
- ADGM N/A
- Average True Range (ATR)
- BOLT 0.03
- ADGM 0.00
- MACD
- BOLT 0.00
- ADGM 0.00
- Stochastic Oscillator
- BOLT 29.16
- ADGM 0.00
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.